# A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA

> **NCT03371212** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Rush University Medical Center** · enrollment: 52 (estimated)

## Conditions studied

- Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium

## Interventions

- **DEVICE:** Dual mobility cohort
- **DEVICE:** Conventional cohort

## Key facts

- **NCT ID:** NCT03371212
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-15
- **Primary completion:** 2035-12-01
- **Final completion:** 2036-12-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371212, "A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03371212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*